1. Home
  2. AVBP vs AMPS Comparison

AVBP vs AMPS Comparison

Compare AVBP & AMPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVBP
  • AMPS
  • Stock Information
  • Founded
  • AVBP 2021
  • AMPS 2009
  • Country
  • AVBP United States
  • AMPS United States
  • Employees
  • AVBP N/A
  • AMPS N/A
  • Industry
  • AVBP
  • AMPS Electric Utilities: Central
  • Sector
  • AVBP
  • AMPS Utilities
  • Exchange
  • AVBP NYSE
  • AMPS Nasdaq
  • Market Cap
  • AVBP 879.2M
  • AMPS 790.4M
  • IPO Year
  • AVBP 2024
  • AMPS N/A
  • Fundamental
  • Price
  • AVBP $21.75
  • AMPS $4.94
  • Analyst Decision
  • AVBP Strong Buy
  • AMPS Buy
  • Analyst Count
  • AVBP 5
  • AMPS 9
  • Target Price
  • AVBP $39.40
  • AMPS $5.06
  • AVG Volume (30 Days)
  • AVBP 172.1K
  • AMPS 2.5M
  • Earning Date
  • AVBP 03-03-2025
  • AMPS 05-08-2025
  • Dividend Yield
  • AVBP N/A
  • AMPS N/A
  • EPS Growth
  • AVBP N/A
  • AMPS N/A
  • EPS
  • AVBP N/A
  • AMPS 0.22
  • Revenue
  • AVBP N/A
  • AMPS $185,992,000.00
  • Revenue This Year
  • AVBP N/A
  • AMPS $30.50
  • Revenue Next Year
  • AVBP N/A
  • AMPS $16.27
  • P/E Ratio
  • AVBP N/A
  • AMPS $22.40
  • Revenue Growth
  • AVBP N/A
  • AMPS 25.90
  • 52 Week Low
  • AVBP $14.35
  • AMPS $2.71
  • 52 Week High
  • AVBP $36.37
  • AMPS $6.00
  • Technical
  • Relative Strength Index (RSI)
  • AVBP 32.12
  • AMPS 65.52
  • Support Level
  • AVBP $21.34
  • AMPS $4.90
  • Resistance Level
  • AVBP $22.75
  • AMPS $4.96
  • Average True Range (ATR)
  • AVBP 1.40
  • AMPS 0.03
  • MACD
  • AVBP -0.14
  • AMPS -0.04
  • Stochastic Oscillator
  • AVBP 8.41
  • AMPS 68.75

About AVBP ARRIVENT BIOPHARMA INC

ArriVent BioPharma Inc is a clinical stage biopharmaceutical company dedicated to the identification, development and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize team's deep drug development experience to maximize the potential of lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.

About AMPS Altus Power Inc.

Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serve commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Their primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.

Share on Social Networks: